HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Takahiro Yamazaki Selected Research

Death Domain Receptors

1/2023Radiation therapy improves CAR T cell activity in acute lymphoblastic leukemia.
1/2021Radiotherapy-exposed CD8+ and CD4+ neoantigens enhance tumor control.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Takahiro Yamazaki Research Topics

Disease

56Neoplasms (Cancer)
01/2024 - 01/2003
10Breast Neoplasms (Breast Cancer)
10/2023 - 11/2014
8Carcinoma (Carcinomatosis)
10/2023 - 06/2013
5Melanoma (Melanoma, Malignant)
01/2024 - 11/2015
5Inflammation (Inflammations)
12/2022 - 01/2020
2Fibrosarcoma
11/2023 - 06/2013
2Lung Neoplasms (Lung Cancer)
11/2023 - 11/2016
2Adenocarcinoma
10/2023 - 01/2022
2Dementia (Dementias)
05/2022 - 11/2020
2Disease Progression
01/2021 - 01/2020
2Triple Negative Breast Neoplasms
01/2021 - 01/2021
2Bites and Stings (Sting)
10/2020 - 01/2019
2Hepatocellular Carcinoma (Hepatoma)
04/2020 - 07/2012
2Stroke (Strokes)
01/2020 - 02/2014
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2019 - 01/2019
2Leukemia
01/2017 - 05/2012
2Neoplasm Metastasis (Metastasis)
03/2016 - 01/2003
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2023
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2023
1Hematologic Neoplasms (Hematological Malignancy)
01/2023
1Type 2 Diabetes Mellitus (MODY)
12/2022
1Non-alcoholic Fatty Liver Disease
12/2022
1Alzheimer Disease (Alzheimer's Disease)
05/2022
1Dystonia (Limb Dystonia)
05/2022
1Mitochondrial Diseases (Mitochondrial Disease)
01/2022
1Wrist Fractures
11/2021
1Hyperglycemia
01/2021
1Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2021
1Cognitive Dysfunction
11/2020
1Asthenopia (Eyestrain)
07/2020

Drug/Important Bio-Agent (IBA)

9AnthracyclinesIBA
06/2016 - 07/2012
7Interferon Type IIBA
01/2022 - 11/2014
7Immune Checkpoint InhibitorsIBA
01/2021 - 01/2016
6Hormones (Hormone)IBA
10/2023 - 01/2020
5AntigensIBA
01/2024 - 01/2016
5Antineoplastic Agents (Antineoplastics)IBA
01/2021 - 06/2013
5Peptides (Polypeptides)IBA
01/2021 - 01/2016
4CytokinesIBA
09/2023 - 05/2012
4Adenosine Triphosphate (ATP)IBA
01/2021 - 04/2013
4Biomarkers (Surrogate Marker)IBA
04/2020 - 01/2019
4Oxaliplatin (Eloxatin)FDA LinkGeneric
06/2016 - 07/2012
3DNA (Deoxyribonucleic Acid)IBA
01/2024 - 09/2012
3Phenobarbital (Luminal)FDA Link
01/2021 - 01/2020
3CarcinogensIBA
01/2021 - 09/2012
3Cytostatic AgentsIBA
01/2021 - 01/2019
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
10/2016 - 11/2013
3InterferonsIBA
02/2016 - 08/2015
2LTX-315IBA
01/2024 - 01/2021
2Medroxyprogesterone Acetate (Depo-Provera)FDA LinkGeneric
10/2023 - 01/2020
2anthraceneIBA
10/2023 - 01/2020
2Death Domain ReceptorsIBA
01/2023 - 01/2021
2EpitopesIBA
12/2022 - 01/2021
2Retinaldehyde (Retinal)IBA
01/2022 - 01/2020
2Estrogen ReceptorsIBA
01/2022 - 01/2021
2Food IngredientsIBA
11/2020 - 01/2020
2Indicators and Reagents (Reagents)IBA
07/2020 - 05/2012
2theasinensin AIBA
01/2020 - 01/2019
2CrizotinibIBA
04/2019 - 01/2019
2HMGB1 Protein (HMG1)IBA
01/2019 - 06/2016
2Caspase 3 (Caspase-3)IBA
01/2019 - 06/2016
2VaccinesIBA
01/2019 - 07/2012
2AntibodiesIBA
01/2019 - 11/2015
2CalreticulinIBA
01/2019 - 09/2012
2ChemokinesIBA
03/2016 - 09/2015
2Chemokine ReceptorsIBA
03/2016 - 09/2015
2Anti-Bacterial Agents (Antibiotics)IBA
11/2015 - 11/2013
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2013 - 01/2008
1Toll-Like Receptors (Toll-Like Receptor)IBA
01/2024
1RNA (Ribonucleic Acid)IBA
01/2024
1AlarminsIBA
01/2024
1Nucleic AcidsIBA
01/2024
1navitoclaxIBA
11/2023
1venetoclaxIBA
11/2023
1Cyclin-Dependent Kinase Inhibitor p16IBA
10/2023
1Caspase 8 (Caspase-8)IBA
10/2023
1AP20187IBA
10/2023
1GalactosidasesIBA
10/2023
1Chimeric Antigen ReceptorsIBA
01/2023
1CarbohydratesIBA
12/2022
1brexpiprazoleIBA
05/2022
1Quetiapine Fumarate (Seroquel)FDA Link
05/2022
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022
1Interleukin-10 (Interleukin 10)IBA
01/2022
1LipopolysaccharidesIBA
01/2022
1PhosphatidylserinesIBA
01/2022
1ElementsIBA
11/2021
1Therapeutic UsesIBA
01/2021
1Cyclin-Dependent Kinase 4IBA
01/2021
1ApolipoproteinsIBA
01/2021
1palbociclibIBA
01/2021
1Histocompatibility Antigens Class IIIBA
01/2021
1AcidsIBA
11/2020
1Mitochondrial DNA (mtDNA)IBA
10/2020
1Triglycerides (Triacylglycerol)IBA
04/2020
1PlatinumIBA
01/2020

Therapy/Procedure

17Therapeutics
01/2021 - 04/2013
14Radiotherapy
10/2023 - 11/2017
11Immunotherapy
11/2023 - 05/2012
9Drug Therapy (Chemotherapy)
11/2020 - 10/2010
1Oral Administration
10/2023